How do I find out if I qualify for a metastatic castration-resistant prostate cancer study in California?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in California to take part?

Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a metastatic castration-resistant prostate cancer trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · California

Metastatic Castration-resistant Prostate Cancer clinical trials in California

We’re tracking 75 recruiting metastatic castration-resistant prostate cancer studies with a site in California — including Phase 1 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in California

NCT06855277RecruitingPhase 3
AAA817 with hormone therapy for advanced prostate cancer
This trial tests a new combination treatment (AAA817 plus a hormone therapy) against standard care for men with advanced PSMA-positive prostate cancer that has spread and stopped responding to a previous hormone therapy. It may be an option if you haven't had certain prior treatments.
Palo Alto, CaliforniaAges 18–100
NCT05939414RecruitingPhase 3
Lutetium prostate cancer treatment for limited PSMA-spread
This Phase 3 trial compares a targeted radiation medicine called lutetium (177Lu) vipivotide tetraxetan versus watchful waiting in people with prostate cancer that has spread to only a few spots. The goal is to see if the treatment can better control the cancer when scans show a small amount of PSMA-positive metastases.
Los Angeles, CaliforniaAges 18–100
NCT07114601RecruitingPhase 1
Study of LY4257496 for people with GRPR-positive solid tumors
This trial tests a new drug, LY4257496, in people with certain types of cancer that have a protein called GRPR on their cells. The study aims to see if the drug can help shrink tumors or slow the cancer's growth.
Duarte, CaliforniaAges 18 years+

Metastatic Castration-resistant Prostate Cancer trials by city in California

Where these studies are running in California

Institutions with a site for the recruiting metastatic castration-resistant prostate cancer studies listed above.

Stanford University · 3 studies
City of Hope Comprehensive Cancer Center
Sansum Clinic
UCSF
University of California Los Angeles
VA Greater Los Angeles Healthcare System
VA Palo Alto Health Care System

What taking part in a metastatic castration-resistant prostate cancer study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Metastatic Castration-resistant Prostate Cancer trials in other states

Common questions

Are there metastatic castration-resistant prostate cancer clinical trials in California?: Yes. We're currently tracking 75 recruiting metastatic castration-resistant prostate cancer studies with a site in California, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a metastatic castration-resistant prostate cancer study in California?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in California to take part?: Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a metastatic castration-resistant prostate cancer trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New metastatic castration-resistant prostate cancer studies open in California regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.